122 related articles for article (PubMed ID: 6890367)
1. Animal experiments on the safety pharmacology of lofexidine.
Graf E; Sieck A; Wenzl H; Winkelmann J
Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367
[TBL] [Abstract][Full Text] [Related]
2. Animal experiments on the cardiovascular effects of lofexidine.
Graf E; Doppelfeld IS; Prop G
Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
[TBL] [Abstract][Full Text] [Related]
3. Toxicology of the combination lofexidine/hydrochlorothiazide.
Friehe H; Fontaine R; Gibson JP; Larson EJ; Sells DM
Arzneimittelforschung; 1982; 32(8a):966-71. PubMed ID: 6890371
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
Dollery CT; Reid JL
Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
[TBL] [Abstract][Full Text] [Related]
5. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
[TBL] [Abstract][Full Text] [Related]
6. Central nervous effects of a new tricyclic antidepressant (amitriptylinoxide).
Wenzl H; Graf E; Sieck A
Arzneimittelforschung; 1978; 28(10b):1874-9. PubMed ID: 261811
[TBL] [Abstract][Full Text] [Related]
7. Acute, subacute and chronic toxicity/Carcinogenicity of lofexidine.
Tsai TH; Beitman RE; Gibson JP; Larson EJ; Friehe H; Fontaine R
Arzneimittelforschung; 1982; 32(8a):955-62. PubMed ID: 6890369
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of lofexidine in pharmacological screening.
Wagener HH; Genthe H
Arzneimittelforschung; 1982; 32(8a):918-23. PubMed ID: 6890365
[TBL] [Abstract][Full Text] [Related]
9. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system.
Saito T; Fukuda T; Sukamoto T; Yoshidomi M; Morimoto Y; Shimohara K; Ito K
Arzneimittelforschung; 1988 Jan; 38(1):66-9. PubMed ID: 2896509
[TBL] [Abstract][Full Text] [Related]
11. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
[TBL] [Abstract][Full Text] [Related]
12. Teratologic and reproductive studies of lofexidine.
Tsai TH; Beitman RE; Gibson JP; Larson EJ
Arzneimittelforschung; 1982; 32(8a):962-6. PubMed ID: 6890370
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. III. Actions on the nervous systems and miscellaneous organs.
Uesaka I; Kubo S; Matsubara I; Kasé Y
Arzneimittelforschung; 1977 Jul; 27(7):1439-45. PubMed ID: 578469
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
[TBL] [Abstract][Full Text] [Related]
15. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on central nervous and sensory systems and other functions.
Yamamoto S; Takemori E; Hasegawa Y; Nakao K; Inukai T; Nomura M; Morino K; Tsuchiyama M; Hasegawa K; Ikeda H
Arzneimittelforschung; 1991 Jun; 41(6):602-7. PubMed ID: 1930347
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological studies of guanabenz: effects of the central nervous system].
Ohata K; Murata T; Sakamoto H; Inoue K; Kobayashi M; Kohno S; Nagasaka Y; Kasai H
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):471-80. PubMed ID: 7160794
[TBL] [Abstract][Full Text] [Related]
17. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
19. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
